Replies to post #509899 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

You are entitled to your own opinion. I disagree with your opinion, and you disagree with my opinion. I am ok with that, and I can live with that.

I believe you underestimate the importance of having a new global standard of care (SOC) for all future ndGBM and rGBM clinical trials. I will stick with what Dr. Pazdur said and believes. As you know, he is the head of the FDA Oncology Center of Excellence (OCE).

I will keep my list of facts the same as they are.

[norisknorewards]

did a lot of digging last night and came up with a nothing burger with respect to any mention what so ever of DC VAX being a part of Orbis nor Breakthrough designation.

i only mention so that folks are not falsely assuming things that (at least publicly) are not factual.

lets not go down another rabbit hole ah la tote bags

[ilovetech]

The healthcare system has it's reputation in the toilet worldwide. I'm astonished at how naively blind people are capable of being. G20 ruling elite/member countries have faced historic backlash from their constituents. People from these countries laugh at how naively we buy into everything that's fed us. There's no limit to the lies we're told and all that's needed is blind acceptance.

[skitahoe]

Mav,

If there are no delays in approving the production facility why should approval slip to next year. I know that the U.K. hasn't announced the acceptance of NWBO's application, and even if they've not quite submitted it yet, even a submission in late September could still gain approval in 2022. I believe we're much closer than that, I'd say the odds are better than even that they've already submitted but we'll only be told when they're accepted.

To me the big thing is acceptance of their production capability, once that occurs all else will fall in place IMHO.

Gary